WallStreetZenWallStreetZen

NASDAQ: VKTX
Viking Therapeutics Inc Stock Ownership - Who owns Viking Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Viking Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Marianna ManciniChief Operating Officer2025-01-0649,115$42.69
$2.10MSell
Brian LianPresident CEO2025-01-06175,490$42.68
$7.49MSell
Brian LianPresident CEO2025-01-0619,000$43.32
$823.02kSell
Greg ZanteChief Financial Officer2025-01-064,700$43.32
$203.60kSell
Marianna ManciniChief Operating Officer2025-01-065,100$43.32
$220.91kSell
Greg ZanteChief Financial Officer2025-01-0645,609$42.69
$1.95MSell
Lawson MacArtneyDirector2024-11-082,000$68.67
$137.33kSell
Lawson MacArtneyDirector2024-11-082,000$5.80
$11.60kBuy
Greg ZanteChief Financial Officer2024-10-2851,000$8.52
$434.52kBuy
Greg ZanteChief Financial Officer2024-10-2826,000$5.80
$150.80kBuy

1 of 9

VKTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VKTX insiders and whales buy or sell their stock.

VKTX Shareholders

What type of owners hold Viking Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.91%16,619,430$537.97MInstitution
Vanguard Group Inc9.12%10,167,614$329.13MInstitution
Ligand Pharmaceuticals Inc5.22%5,819,383$188.37MInsider
Blackrock Inc4.83%5,380,323$174.16MInstitution
Blackrock Inc 14.83%5,380,323$174.16MInstitution
State Street Corp4.19%4,674,067$151.30MInstitution
Brian Lian2.12%2,366,570$76.61MInsider
Jpmorgan Chase Co1.90%2,116,438$68.51MInstitution
Morgan Stanley1.68%1,874,845$60.69MInstitution
Geode Capital Management LLC1.67%1,863,667$60.33MInstitution

1 of 3

VKTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VKTX74.05%9.01%Net SellingNet Selling
RYTM88.08%11.92%Net SellingNet Selling
ACLX45.58%54.42%Net SellingNet Selling
APLS75.35%24.65%Net SellingNet Selling
CRNX87.15%12.85%Net SellingNet Selling
View Top Biotech Stocks

Viking Therapeutics Stock Ownership FAQ

Who owns Viking Therapeutics?

Viking Therapeutics (NASDAQ: VKTX) is owned by 74.05% institutional shareholders, 9.01% Viking Therapeutics insiders, and 16.93% retail investors. Ligand Pharmaceuticals Inc is the largest individual Viking Therapeutics shareholder, owning 5.82M shares representing 5.22% of the company. Ligand Pharmaceuticals Inc's Viking Therapeutics shares are currently valued at $194.95M.

If you're new to stock investing, here's how to buy Viking Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.